This HTML5 document contains 187 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n16	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n14	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149384/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149384/core-reimbursement/
n3	http://linked.opendata.cz/ontology/sukl/
n7	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149384/price/
n20	http://linked.opendata.cz/resource/sukl/specialization-restriction/
skos	http://www.w3.org/2004/02/skos/core#
n15	http://linked.opendata.cz/resource/sukl/indgroup/
n13	http://linked.opendata.cz/resource/sukl/packing/
n19	http://linked.opendata.cz/resource/sukl/company/
n5	http://linked.opendata.cz/resource/sukl/active-ingredient/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n18	http://linked.opendata.cz/resource/sukl/registration-state/
n6	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149384/price-of-originator/
xsdh	http://www.w3.org/2001/XMLSchema#
n11	http://www.emea.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000788/
n9	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149384/reimbursement/
n17	http://linked.opendata.cz/resource/sukl/df/
n8	http://linked.opendata.cz/resource/atc/

Statements

Subject Item

n2:0149384

rdf:type

n3:MedicinalProductPackaging

dcterms:title

ECALTA 100 MG

skos:notation

0149384

n3:hasATCCode

n8:J02AX06

n3:hasActiveIngredient

n5:ANIDULAFUNGINUM

n3:hasDefinedDailyDose

n14:ddd

n3:hasDosageForm

n17:INF-PLV-CSL-IVN

n3:hasPackagingSize

1

n3:hasPacking

n13:VIA

n3:hasRegistrationHolder

n19:PFIGB

n3:hasRegistrationState

n18:R

n3:hasRouteOfAdministration

n16:IVN

n3:hasStrength

100MG

n3:hasIndicationGroup

n15:26

n3:hasSpecializationRestriction

n20:ATB

n3:containsDefinedDailyDoses

1.0

n3:hasRegistrationCode

EU/1/07/416/002

n3:hasTitleSupplement

INF PLV CSL 1X100MG

n3:containsUsualTherapeuticalDailyDoses

1

n3:hasBreakMarketingDate

2015-01-26+01:00

n3:hasCoreReimbursementSpecification

n4:2013-01-01 n4:2013-01-05 n4:2015-05-01 n4:2015-06-01 n4:2015-04-01 n4:2015-04-02 n4:2015-07-01 n4:2015-07-02 n4:2013-11-01 n4:2013-12-01 n4:2013-09-01 n4:2013-10-01 n4:2014-03-01 n4:2014-04-01 n4:2014-01-01 n4:2014-02-01 n4:2013-04-01 n4:2013-05-01 n4:2013-02-01 n4:2013-03-01 n4:2013-08-01 n4:2013-08-03 n4:2013-06-01 n4:2013-07-01 n4:2014-11-19 n4:2014-12-01 n4:2014-10-02 n4:2014-11-01 n4:2015-02-01 n4:2015-03-01 n4:2015-01-01 n4:2015-01-13 n4:2014-06-13 n4:2014-07-01 n4:2014-05-01 n4:2014-06-01 n4:2014-09-01 n4:2014-10-01 n4:2014-07-03 n4:2014-08-01

n3:hasPriceOfOriginatorSpecification

n6:2014-03-01 n6:2014-04-01 n6:2014-01-01 n6:2014-02-01 n6:2013-11-01 n6:2013-12-01 n6:2013-09-01 n6:2013-10-01 n6:2014-09-01 n6:2014-10-01 n6:2014-07-03 n6:2014-08-01 n6:2014-06-13 n6:2014-07-01 n6:2014-05-01 n6:2014-06-01 n6:2013-01-01 n6:2013-01-05 n6:2013-08-01 n6:2013-08-03 n6:2013-06-01 n6:2013-07-01 n6:2013-04-01 n6:2013-05-01 n6:2013-02-01 n6:2013-03-01 n6:2015-02-01 n6:2015-03-01 n6:2015-01-01 n6:2015-01-13 n6:2014-11-19 n6:2014-12-01 n6:2014-10-02 n6:2014-11-01 n6:2015-07-01 n6:2015-07-02 n6:2015-05-01 n6:2015-06-01 n6:2015-04-01 n6:2015-04-02

n3:hasPriceSpecification

n7:2013-02-01 n7:2013-03-01 n7:2013-04-01 n7:2013-05-01 n7:2013-06-01 n7:2013-07-01 n7:2013-08-01 n7:2013-08-03 n7:2013-09-01 n7:2013-10-01 n7:2013-11-01 n7:2013-12-01 n7:2014-01-01 n7:2014-02-01 n7:2014-03-01 n7:2014-04-01 n7:2013-01-01 n7:2013-01-05 n7:2015-04-01 n7:2015-04-02 n7:2015-05-01 n7:2015-06-01 n7:2015-07-01 n7:2015-07-02 n7:2014-05-01 n7:2014-06-01 n7:2014-06-13 n7:2014-07-01 n7:2014-07-03 n7:2014-08-01 n7:2014-09-01 n7:2014-10-01 n7:2014-10-02 n7:2014-11-01 n7:2014-11-19 n7:2014-12-01 n7:2015-01-01 n7:2015-01-13 n7:2015-02-01 n7:2015-03-01

n3:hasReimbursementSpecification

n9:2013-01-01 n9:2013-01-05 n9:2013-04-01 n9:2013-05-01 n9:2013-02-01 n9:2013-03-01 n9:2013-08-01 n9:2013-08-03 n9:2013-06-01 n9:2013-07-01 n9:2014-11-19 n9:2014-12-01 n9:2014-10-02 n9:2014-11-01 n9:2015-02-01 n9:2015-03-01 n9:2015-01-01 n9:2015-01-13 n9:2015-05-01 n9:2015-06-01 n9:2015-04-01 n9:2015-04-02 n9:2015-07-01 n9:2015-07-02 n9:2013-11-01 n9:2013-12-01 n9:2013-09-01 n9:2013-10-01 n9:2014-03-01 n9:2014-04-01 n9:2014-01-01 n9:2014-02-01 n9:2014-06-13 n9:2014-07-01 n9:2014-05-01 n9:2014-06-01 n9:2014-09-01 n9:2014-10-01 n9:2014-07-03 n9:2014-08-01

n3:hasResumedMarketingDate

2015-02-02+01:00 2011-01-24+01:00

n3:hasUsualTherapeuticalDailyDose

n14:utdd

n3:pilFile

http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000788%2FWC500020673.pdf

n3:pilUri

n11:WC500020673.pdf

n3:spcFile

http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000788%2FWC500020673.pdf

n3:spcUri

n11:WC500020673.pdf